Citadel Advisors
LJPC

Citadel Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Citadel Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,300
Closed -$70K – 15424
2021
Q2 		$70K Buy
16,300
+3,500
+27% +$15K ﹤0.01% 13167
2021
Q1 		$54K Buy
+12,800
New +$70.5K ﹤0.01% 12874
2020
Q4 		– Sell
-35,800
Closed -$144K – 11964
2020
Q3 		$144K Sell
35,800
-600
-2% -$2.48K ﹤0.01% 9029
2020
Q2 		$155K Sell
36,400
-13,700
-27% -$83.4K ﹤0.01% 8717
2020
Q1 		$210K Buy
50,100
+29,300
+141% +$185K ﹤0.01% 7937
2019
Q4 		$82K Buy
20,800
+3,700
+22% +$21.9K ﹤0.01% 8627
2019
Q3 		$150K Sell
17,100
-8,800
-34% -$83.1K ﹤0.01% 8304
2019
Q2 		$240K Buy
+25,900
New +$195K ﹤0.01% 7929
2018
Q3 		– Sell
-9,400
Closed -$274K – 10183
2018
Q2 		$274K Sell
9,400
-8,600
-48% -$265K ﹤0.01% 7365
2018
Q1 		$536K Sell
18,000
-3,700
-17% -$119K ﹤0.01% 5770
2017
Q4 		$698K Buy
21,700
+2,900
+15% +$94.8K ﹤0.01% 5172
2017
Q3 		$654K Buy
+18,800
New +$605K ﹤0.01% 4940
2016
Q4 		– Sell
-8,600
Closed -$205K – 8474
2016
Q3 		$205K Buy
+8,600
New +$162K ﹤0.01% 6275
2016
Q1 		– Sell
-2,300
Closed -$62K – 9360
2015
Q4 		$62K Sell
2,300
-8,800
-79% -$240K ﹤0.01% 7134
2015
Q3 		$308K Buy
+11,100
New +$350K ﹤0.01% 5528

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors's LJPC Position: Q2 2022 in Review

Citadel Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2022, closing a stake of 50,873 shares — an estimated $217K sold.

Citadel Advisors first reported a position in LJPC in Q3 2015 and held it in 18 quarters. The position peaked at $8.91M in Q2 2017. 41 funds tracked by Wall St. Rank hold LJPC as of Q2 2022.

  • Citadel Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 50,873 La Jolla Pharmaceutical Company shares in Q2 2022, an estimated $217K.
  • Citadel Advisors first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 18 quarters.
  • Citadel Advisors's La Jolla Pharmaceutical Company position peaked at $8.91M in Q2 2017.
  • 41 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.